BioCryst Pharmaceuticals, Inc. (BCRX)
8.48
-0.02
(-0.24%)
USD |
NASDAQ |
Mar 06, 16:00
8.48
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Market Cap : 2.127B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 189.22M |
| Lantheus Holdings, Inc. | 4.812B |
| Plus Therapeutics, Inc. | 39.68M |
| BioStem Technologies, Inc. | 87.35M |
| Iovance Biotherapeutics, Inc. | 2.113B |
Market Cap Related Metrics
| PE Ratio | 7.048 |
| PS Ratio | 2.119 |
| Price to Free Cash Flow | 5.661 |
| Price | 8.48 |
| Earnings Yield | 14.19% |
| Operating PE Ratio | 5.436 |
| Normalized PE Ratio | 6.739 |